99mTc-rhAnnexin V-128 Imaging of Apoptosis and Cardiotoxicity in Relationship to Ventricular Function in Patients With Early Stage Breast Cancer Receiving Doxorubicin-Based Chemotherapy
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 02 Feb 2017
At a glance
- Drugs Tc-99m annexin V 128 (Primary)
- Indications Cardiomyopathies
- Focus Diagnostic use
- Sponsors Advanced Accelerator Applications
- 23 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Sep 2017.
- 16 Jun 2016 Planned primary completion date changed from 1 Oct 2016 to 1 Dec 2016.
- 16 Jun 2016 Status changed from not yet recruiting to active, no longer recruiting.